(Q38128957)

29 August 2017

title

PET approaches for diagnosis of dementia (English)

1 reference

29 August 2017

0 references

K Ishii

1

1 reference

29 August 2017

publication date

14 August 2013

1 reference

American Journal of Neuroradiology

29 August 2017

published in

1 reference

29 August 2017

volume

35

1 reference

29 August 2017

issue

11

1 reference

29 August 2017

page(s)

2030-2038

1 reference

Clinical application of positron emission tomography for diagnosis of dementia

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Relatively preserved hippocampal glucose metabolism in mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Whither the hippocampus? FDG-PET hippocampal hypometabolism in Alzheimer disease revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Comparison of regional brain volume and glucose metabolism between patients with mild dementia with lewy bodies and those with mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Comparison of 18F-FDG PET and optimized voxel-based morphometry for detection of Alzheimer's disease: aging effect on diagnostic performance

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Cerebral glucose metabolism in patients with AD and different APOE genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Computer-assisted system for diagnosis of Alzheimer disease using data base- independent estimation and fluorodeoxyglucose- positron-emission tomography and 3D-stereotactic surface projection

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Detecting hippocampal hypometabolism in Mild Cognitive Impairment using automatic voxel-based approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Clinical applications of PET amyloid imaging: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Imaging amyloid deposition in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Brain amyloid and cognition in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

In vivo amyloid imaging with PET in frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Features of regional cerebral glucose metabolism abnormality in corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Does fetal endoscopic closure of the myelomeningocele prevent loss of neurologic function in spina bifida aperta?

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Early evaluation of cerebral metabolic rate of glucose (CMRglu) with 18F-FDG PET/CT and clinical assessment in idiopathic normal pressure hydrocephalus (INPH) patients before and after ventricular shunt placement: preliminary experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

[(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A3695

21 January 2018

Identifiers

DOI

10.3174/AJNR.A3695

1 reference

29 August 2017

1 reference